Health Care Up as Lilly's Weight Loss Drug - Health Care Roundup

Health-care companies rose amid optimism about demand for weight-loss drugs.

Eli Lilly shares rose after the drug giant said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, significantly more than what existing drugs can provide.

A Democratic effort to extend federal health-insurance subsidies failed in the Senate on Thursday, with just weeks to go until millions of Americans covered under the Affordable Care Act face soaring costs for their coverage when the payments lapse.

French drug maker Sanofi said two bleeding disorder treatments for both chronic and acute conditions have been approved in China, expanding its hematology offerings in the country.

Write to Rob Curran at [e-mail]

(END) Dow Jones Newswires

12-11-25 1715ET